The pulmonary hypertension drugs market is witnessing robust growth fueled by innovation in targeted therapies and increasing disease prevalence worldwide. Market dynamics are shaped by evolving clinical treatment protocols and expanding patient populations, enabling significant business growth opportunities within specialized segments.Market Size and Overview The Global Pulmonary Hypertension...